Cadila Healthcare PAT seen down 16% at Rs 192cr

NEW DELHI: Cadila Healthcare Ltd will announce its quarterly results on Monday. The company is expected to post a net profit of Rs 192 crore for the quarter ended June 2012, down 16 per cent YoY from Rs 230 crore, according to ET Now estimates.

Net sales are expected to have grown 4 per cent to Rs 1,466 crore in the first quarter from Rs 1,173 crore in the year-ago period.

Earnings before interest, taxes, depreciation and amortization ( EBITDA) -- the profitability measure of the company -- are expected to have inched up by 3 per cent to Rs 311 crore from Rs 303 crore in the June 2011 quarter.

Margins for the pharmaceutical major are seen at 21.2 per cent compared to 25.8 per cent.

10 things to watch out for:

Revenue growth aided by growth in domestic markets

See domestic growth around 28 per cent, export growth by around 22 per cent

Domestic growth to be aided by consolidation of Biochem

Export revenues on Nesher acquisition, currency impact

Export growth to be restrained due to US FDA ban

Company got US FDA clearance in Moraiya plant in Q2

Lower income to be received from Abbott for milestones

Margins to be hit on consolidation of Biochem

MTM losses and higher interest costs to hit profits

Profits to be hit by higher tax outgo